Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11835527 Deglycosylation methods for electrophoresis of glycosylated proteins

Patent 11835527 was granted and assigned to Regeneron Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

0

Current Assignee

Regeneron Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shao-Chun Wang0

Hunter Chen0

Yiming Zhao0

Gabriel Carreau0

Ying Wang0

Timothy Riehlman0

Date of Patent

December 5, 2023

0

Patent Application Number

171531500

Date Filed

January 20, 2021

0

Patent Citations

US Patent 8043617 Human antibodies to human IL-6 receptor

0

US Patent 6924372 Benzopyrylo-polymethine-based hydrophilic markers

0

US Patent 7087411 Fusion protein capable of binding VEGF

0

US Patent 7279159 VEGF inhibitor polypeptides

0

US Patent 7582298 High affinity antibodies to human IL-6 receptor

0

US Patent 7879984 Human antibodies to human CD20 and method of using thereof

0

US Patent 9079948 Human antibodies to Fel d1 and methods of use thereof

0

US Patent 9132192 Anti-EGFR antibodies and uses thereof

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

Patent abstract

The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11835527 Deglycosylation methods for electrophoresis of glycosylated proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool